Drug profile · INN
desonide
DESOWEN
desonide (DESOWEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — desonide
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 5
- Programs
- 33
- Data quality
- 0.84
Quick answer
desonide (DESOWEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11413296
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted -
US 9119863
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted -
US 8975243
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted -
US 8497258
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted -
US 8324192
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted
Frequently asked questions
What is desonide?
desonide (DESOWEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for desonide?
DESOWEN is a marketed brand name for desonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desonide?
desonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.